CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.

BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

The new director of the FDA’s device center contrasted a European rule with the U.S.’s lack of mandatory reporting requirements for potential device shortages.